The Journal of Immunology, Vol 147, Issue 11 3728-3735, Copyright © 1991 by American Association of Immunologists

ARTICLES

Induction of phorbol ester responsiveness in conventional B cells after activation via surface Ig

TL Rothstein, DL Kolber, TP Murphy and DP Cohen
Department of Medicine, Boston University Medical Center, MA 02118.

The signals required to induce S phase entry in murine splenic B cells were found to be altered by prolonged treatment with low doses of anti- Ig antibody. Whereas fresh splenic B cells are stimulated by the combination of a phorbol ester protein kinase C agonist plus a calcium ionophore, anti-Ig-treated splenic B cells were stimulated by phorbol ester alone, in the absence of a comitogen. The majority of these phorbol ester responsive B cells expressed CD5. The phorbol ester responses of anti-Ig-treated splenic B cells paralleled those previously reported for untreated peritoneal CD5+ B cells in a number of respects: responses were not idiosyncratic to phorbol esters but occurred with nonphorbol protein kinase C agonists; phorbol ester responses were enhanced by IL-4; and, phorbol ester responses occurred rapidly and were greater at 24 than at 48 h. However, the effect of agents that act to raise intracellular levels of cAMP distinguished between anti-Ig-treated splenic B cells and untreated peritoneal B cells in that the phorbol ester responses of the former were enhanced whereas the responses of the latter were inhibited. The present results add a functional dimension to the phenotypic similarity between splenic B cells treated with anti-Ig and resident peritoneal B cells that constitutively express CD5; however, some differences in behavior were noted.

This article has been cited by other articles:

				I. Debnath, K. M. Roundy, J. J. Weis, and J. H. Weis Defining In Vivo Transcription Factor Complexes of the Murine CD21 and CD23 Genes J. Immunol., June 1, 2007; 178(11): 7139 - 7150. [Abstract] [Full Text] [PDF]

				R. Berland and H. H. Wortis Normal B-1a cell development requires B cell-intrinsic NFATc1 activity PNAS, November 11, 2003; 100(23): 13459 - 13464. [Abstract] [Full Text] [PDF]

				T. L. Rothstein Two B-1 or Not To Be One J. Immunol., May 1, 2002; 168(9): 4257 - 4261. [Abstract] [Full Text] [PDF]

				M. J. Chumley, J. M. Dal Porto, S. Kawaguchi, J. C. Cambier, D. Nemazee, and R. R. Hardy2 A VH11V{kappa}9 B Cell Antigen Receptor Drives Generation of CD5+ B Cells Both In Vivo and In Vitro J. Immunol., May 1, 2000; 164(9): 4586 - 4593. [Abstract] [Full Text] [PDF]

				D. A. Tanguay, T. P. Colarusso, S. Pavlovic, M. Irigoyen, R. G. Howard, J. Bartek, T. C. Chiles, and T. L. Rothstein Early Induction of Cyclin D2 Expression in Phorbol Ester-responsive B-1 Lymphocytes J. Exp. Med., June 7, 1999; 189(11): 1685 - 1690. [Abstract] [Full Text] [PDF]

				J. G. Karras, Z. Wang, L. Huo, R. G. Howard, D. A. Frank, and T. L. Rothstein Signal Transducer and Activator of Transcription-3 (STAT3) Is Constitutively Activated in Normal, Self-renewing B-1 Cells but Only Inducibly Expressed in Conventional B Lymphocytes J. Exp. Med., March 17, 1997; 185(6): 1035 - 1042. [Abstract] [Full Text] [PDF]